Packages (Simulation)
Image (II)
-
Figure. Western Blot; Sample: Recombinant C4, Gallus.
-
Western Blot; Sample: Gallus Serum;
Primary Ab: 5µg/ml Rabbit Anti-Gallus C4 Antibody
Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
Quality Guarantee
Instruction Manual
Certificate
Polyclonal Antibody to Complement Component 4 (C4)
- Product No.PAA888Ga01
- Organism SpeciesChicken (Gallus) Same name, Different species.
- SourcePolyclonal antibody preparation
- HostRabbit
- Potencyn/a
- Ig Type IgG
- PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
- LabelNone
- Immunogen RPA888Ga01-Recombinant Complement Component 4 (C4)
- Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
- TraitsLiquid
- Concentration500µg/mL
- Organism Species Moren/a
- ApplicationsWB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies. - DownloadInstruction Manual
- UOM 20µl100µl 200µl 1ml 10ml
- FOB
US$ 103
US$ 239
US$ 342
US$ 855
US$ 3420
For more details, please contact local distributors!
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against C4. It has been selected for its ability to recognize C4 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.5-5µg/mL;
Immunohistochemistry: 5-50µg/mL;
Immunocytochemistry: 5-50µg/mL;
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
GIVEAWAYS
INCREMENT SERVICES
| Magazine | Citations |
| Journal of Clinical Immunology | Complement activation contributes to the injury and outcome of kidney in human anti-glomerular basement membrane disease. PubMed: 22941511 |
| British Journal of Pharmacology | The suppression of Brd4 inhibits peripheral plasma cell differentiation and exhibits therapeutic potential for systemic lupus erythematosus |
| Catalog No. | Related products for research use of Chicken (Gallus) Organism species | Applications (RESEARCH USE ONLY!) |
| RPA888Ga01 | Recombinant Complement Component 4 (C4) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA888Ga01 | Polyclonal Antibody to Complement Component 4 (C4) | WB; IHC; ICC; IP. |